Navigation Links
UT Southwestern researcher awarded Gates Foundation grant for novel vaccine development
Date:10/22/2008

DALLAS Oct. 22, 2008 The Bill and Melinda Gates Foundation announced today that it has awarded a UT Southwestern Medical Center scientist a grant to pursue innovative vaccine research.

The $100,000 grant to Dr. Ellen Vitetta, director of the Cancer Immunobiology Center at UT Southwestern, is one of 104 grants awarded in the first funding round of the Grand Challenges Explorations program, a $100 million, five-year initiative to promote innovation in global health. Additional funding of $1 million or more will be available for projects that show promise, according to the Gates Foundation.

Dr. Vitetta's work will focus on a new approach to developing "mimetic vaccines," which would be based on using synthetic molecules called peptoids to generate a protective immune response to a given pathogen. Dr. Thomas Kodadek, professor of internal medicine and an expert in peptoid chemistry, is a collaborator on the project.

Currently, vaccines are developed using dead or attenuated microbes, or bits and pieces of the infectious agent itself, as a basis for stimulating the human immune system to produce antibodies, or infection-fighting agents, against the disease. Dr. Vitetta's research group will screen thousands of peptoids for their ability to bind to pre-made monoclonal antibodies that are already known to neutralize all varieties of a given pathogen. For example, the researchers will look for peptoids that bind to antibodies that recognize structural features shared by all HIV strains.

"The key advantage to using peptoids to develop mimetic vaccines is that these vaccines would not be limited in their effectiveness to a particular strain or subspecies of a given virus, but rather recognize all viruses of each type. Furthermore huge libraries of peptoids can be made and screened," said Dr. Vitetta, who holds the Scheryle Simmons Patigian Distinguished Chair in Cancer Immunobiology.

Once promising peptoids are identified, they will be attached to "carriers" and tested in mice to determine whether they can actually elicit antibodies that neutralize the pathogen. Dr. Vitetta said the challenge and novelty of this approach is to demonstrate that these anti-peptoid antibodies can mimic those the body produces against the actual native pathogen and confer protective immunity.

"This is high-risk, high-impact research, meaning that there is a high risk of failure," Dr. Vitetta said. "But if our experiments are successful, we hope to identify peptoid mimetics that recognize all variants of HIV, and if we are extremely lucky, we will have a useful vaccine for HIV, which will have tremendous impact. Our work could also open the door for vaccines against other pathogens, such as West Nile virus, hepatitis C and influenza. Even if we fail entirely, we will gain a great deal of insight into what we need to do to make mimetic vaccines work."


'/>"/>

Contact: Amanda Siegfried
amanda.siegfried@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

Related biology news :

1. RSV may hide in the lungs, lead to asthma, UT Southwestern researchers report
2. Waste from gut bacteria helps host control weight, UT Southwestern researchers report
3. Antidepressants need new nerve cells to be effective, UT Southwestern researchers find
4. Limiting fructose may boost weight loss, UT Southwestern researcher reports
5. UT Southwestern researchers identify new targets for RNAs that regulate genes
6. UT Southwestern researchers create molecule that nudges nerve stem cells to mature
7. Geology and biology meet in the history of US southwestern desert surface waters
8. Mouse model developed at UT Southwestern mimics hyperglycemia, aids in diabetes research
9. Gene mutations in mice mimic human-like sleep disorder, UT Southwestern researchers find
10. UT Southwesterns Mangelsdorf elected to National Academy of Sciences
11. NIH awards $6.5 million grant to UT Southwestern to develop new antibiotic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... India , April 13, 2017 According to ... Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, ... MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 Billion ... Growth Rate (CAGR) of 17.3%. ... MarketsandMarkets ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... AMSTERDAM , April 20, 2017 Dutch philosopher Koert ... of ,Next Nature, at the University of Technology in Eindhoven - has ... In this letter, he calls on humanity to avoid becoming a slave and ... race. ... Dutch philosopher Koert van Mensvoort – founder of ...
(Date:4/19/2017)... (PRWEB) , ... April 18, 2017 , ... A number ... advances. This webinar, which is part of the Protein and Cell Analysis Education ... and outline where this technology fits in current and future applications. , Many ...
(Date:4/19/2017)... ... 2017 , ... ThermaGenix, the PCR Improvement Company, announces the ... other early achievements at ThermaGenix, including the business formation and licensing agreements, and ... use proceeds from the Series A-1 round to:, , ...
(Date:4/19/2017)... April 19, 2017  As a Bronze ... Heroin Summit ,  Proove® Biosciences, Inc. announces ... environmental, and lifestyle factors to accurately predict prescription ... of Southern California (USC), the Interventional Pain Institute ... publish results showing that Proove Opioid Risk® accurately ...
Breaking Biology Technology: